Sign in

NCT07172243Recruiting

BE.Amycon Biobank & Data Registry UZ Leuven

BE.Amycon Biobank & Data Registry UZ Leuven: Human Body Material (HBM) Collection and Data Collection of Patients With Amyloidosis

Source: ClinicalTrials.gov · Last updated 25 Sept 2026

Brief summary (registry, in English)

The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".

Status (registry)
Recruiting
Study type
Observational
Enrollment
505 (estimated)
First submitted
20 Aug 2025
Start date
24 Sept 2025
Primary completion date
30 Sept 2029
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Diseases
Amyloidosis
NCT number
NCT07172243

What you commit to

  • Study type: Observational
  • Planned participants: 505
  • From 24 Sept 2025 to the primary completion date, 30 Sept 2029
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Not willing to sign informed consent
  • Not able to sign informed consent

Who the study is looking for

  • Provide consent and sign informed consent form
  • Age 18 years or older
  • Diagnosis of amyloidosis (suspected or confirmed, any subtypes)
  • For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UZ Leuven Gasthuisberg - cardiology
Coordinator of this site? Confirm its status
LeuvenBelgiumRecruiting
UZ Leuven Gasthuisberg - hematology
Coordinator of this site? Confirm its status
LeuvenBelgiumRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.